Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Consumer Discretionary · ·
$31.62
▲ $0.81 (+2.6%)
Market data updated: 09/22 03:05 AM
Fundamentals updated: 09/21/2026
News analyzed: 09/22/2026
Market Cap
$535.88M
Day Range
$30.08 - $31.68
52-Week Range
$11.50 - $73.68
Beta
—
Next Earnings
05.11.2026
Support
$21.16
Resistance
$42.47
CTEV is a stock from the Consumer Cyclical sector — Retail, automotive, and leisure — demand rises and falls with economic sentiment and consumers' disposable income.
-44.4% (1Y)
Strengths: 9/30 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Earnings per share (EPS) growth
Earnings per share (EPS) growth: 83.0%
Growth
Biggest negative driver
Net margin
Net margin: -29.4% (negative)
Fundamental
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
50
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
today · $30.81
Evidence: Panic-selling score jumped from 14 to 43 day-over-day
What happened after
Still awaiting outcome
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
62
Quality
63
Value
50
Momentum
29
Risk
32
Sentiment
100
Fundamental
42
Institutional
82
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of **Claritev Corporation** has centered on its strong financial performance and analyst optimism. The company’s Q2 2026 earnings surpassed expectations, prompting upward revisions in sales guidance and multiple price target increases from firms like Barclays ($40), Wells Fargo ($30), and Fintel ($46.75). Claritev also expanded its partnership with **Marpai** to enhance healthcare cost integrity services, while insider selling and analyst discussions highlighted growth potential amid leverage risks. Events and investor updates dominated headlines.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Claritev Corporation. News trend score: 100. Reason: 10 of the last 20 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
38
🎯 Conviction (vs. Emotion)
50
Psychology
43
Fundamentals
42
Technical
29
Valuation
50
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+5%
Market Narrative
53
Fundamental Reality
50
Narrative Gap
+3
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior for CTEV suggests a dominant euphoric state, where price momentum and extreme positive sentiment far exceed fundamental justification. Herding aligns with peers’ identical movement, while FOMO and overconfidence reinforce the disconnect between price and reality. The 24-point narrative gap further indicates investors may be ignoring downside risks. The key question is whether this disconnect will persist or if a correction will test the overvalued position.
Updated: 09/08/2026, 05:31 PM
What could change this?
👥 What the crowd believes
"Barclays analyst raises price target from $28 to $40 (article 3)"
"Marpai expands relationship with Claritev to reduce healthcare costs (article 4)"
"CTEV reported better-than-expected Q2 results and raised FY26 sales guidance (article 10)"
"Citigroup maintains Buy rating with raised price target to $45 (article 11)"
🧠 Market Brain events driving this
📈 7D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 97/100
🔴 Weakest match
Philip Fisher — 25/100
🗣️ Why do they disagree?
The stark divide in verdicts for CTEV reflects deep methodological differences in how these investors assess risk, growth, and market psychology. Thorstein Veblen and Peter Lynch’s high scores suggest they see strong alignment between the company’s growth and intrinsic value or underpriced potential, prioritizing qualitative real-world impact or relative undervaluation. In contrast, the majority of methodologies—particularly those emphasizing volatility, market cycles, or risk—score poorly, warning of overbought conditions, liquidity risks, or late-cycle dangers. Fisher, Mackay, and Marks’ low scores highlight skepticism toward the stock’s quality, crowd-driven hype, or valuation, while Graham’s split verdict underscores its failure to meet even his conservative margin-of-safety criteria. The contrast between Lynch’s optimism and Marks’ caution underscores whether the stock’s momentum is a sustainable trend or a speculative bubble.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 97
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 89
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 75
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 64
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 52
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 52
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 50
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 44
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 42
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 42
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 41
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 39
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🔴 33
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 31
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 25
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 6
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 20%
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (2 bullish · 9 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
3.0%
Net Margin
-29.4%
EBITDA Margin
3.0%
ROE
163.5%
ROA
-5.8%
ROIC
—
EPS
-$17.30
Cash
$16.81M
Total Debt
$4.63B
Current Ratio
0.86
Debt/Equity
-26.61
How is Fair Value calculated? →
Current Price
$31.62
Estimated Fair Value (DCF)
-$290.75
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
⚠️ Extreme
Model output is extreme — likely a data/model limitation for this stock, not a reliable fair-value read.
Year 1 Growth Rate
-3.5%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -3.5% | $-11.85M | $-10.87M |
| 2 | -2.0% | $-11.62M | $-9.78M |
| 3 | -0.5% | $-11.56M | $-8.93M |
| 4 | 1.0% | $-11.68M | $-8.27M |
| 5 | 2.5% | $-11.97M | $-7.78M |
Base FCF (last actual year)
$-12.28M
Terminal Value
$-188.72M
Present Value of Terminal Value
$-122.65M
Enterprise Value
$-168.28M
Net Debt
$4.61B
Equity Value
$-4.78B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
-$10.58
Tangible Book Value per Share (Tangible NAV)
-$271.64
Sentiment based on basic keywords (not AI) — 10 positive, 10 neutral, 0 negative out of the last 20 articles.
Yahoo · 17.9.2026
SeekingAlpha · 15.9.2026
SeekingAlpha · 15.9.2026
Yahoo · 15.9.2026
Yahoo · 10.9.2026
Business Wire · 10.9.2026
Yahoo · 8.9.2026
Insider Monkey · 8.9.2026
Fintel · 28.8.2026
Yahoo · 27.8.2026
Business Wire · 27.8.2026
Benzinga · 21.8.2026
Business Wire · 17.8.2026
Benzinga · 17.8.2026
Motley Fool · 14.8.2026
Simply Wall St. · 14.8.2026
MT Newswires · 12.8.2026
Benzinga · 12.8.2026
Benzinga · 10.8.2026
Benzinga · 10.8.2026
Claritev Corporation (CTEV) currently has a StockIQ AI score of 50/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
CTEV currently scores 50/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
CTEV's technical score is 29/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Earnings per share (EPS) growth: 83.0%; Net income growth: 82.7%; Operating margin is stable or improving over time.
Based on the real signals StockIQ computed: Net margin: -29.4% (negative); ATR: 8.0% of price; Current ratio: 0.86.
StockIQ has no recorded dividend payment history for CTEV.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 14 purchases and 3 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Dalton Travis | Open Market Purchase | 28.8.2026 | 52,322 | +1,950 | $38.48 |
| Dalton Travis | Open Market Purchase | 28.8.2026 | 1,950 | +1,950 | $38.48 |
| Dalton Travis | Open Market Purchase | 27.8.2026 | 50,372 | +4,500 | $38.81 |
| Dalton Travis | Open Market Purchase | 27.8.2026 | 4,500 | +4,500 | $38.81 |
| Misencik Tiffani | Open Market Sale | 14.8.2026 | 8,850 | -8,850 | $40.07 |
| Mintz William B. | Open Market Sale | 10.8.2026 | 8,431 | -8,431 | $34.24 |
| Mintz William B. | Open Market Sale | 10.8.2026 | 71,195 | -8,431 | $34.24 |
| Garis Douglas Michael | Tax Withholding in Shares | 5.8.2026 | 11,711 | -11,711 | $26.13 |
| Mintz William B. | Tax Withholding in Shares | 5.8.2026 | 3,622 | -3,622 | $26.13 |
| Garis Douglas Michael | Tax Withholding in Shares | 5.8.2026 | 194,441 | -11,711 | $26.13 |
| Mintz William B. | Tax Withholding in Shares | 5.8.2026 | 79,626 | -3,622 | $26.13 |
| Albinson Brock | Grant/Award from Employer | 30.6.2026 | 3,649 | +3,649 | — |
| Albinson Brock | Grant/Award from Employer | 30.6.2026 | 33,842 | +3,649 | — |
| Carol Nutter | Open Market Purchase | 9.6.2026 | 875 | +875 | $28.41 |
| Carol Nutter | Open Market Purchase | 9.6.2026 | 46,941 | +875 | $28.41 |
| Prince John Michael | Open Market Purchase | 19.5.2026 | 10,000 | +10,000 | $16.00 |
| Prince John Michael | Open Market Purchase | 19.5.2026 | 31,662 | +10,000 | $16.00 |
| Dalton Travis | Open Market Purchase | 18.5.2026 | 11,200 | +11,200 | $11.88 |
| Kim Michael | Open Market Purchase | 18.5.2026 | 3,000 | +3,000 | $16.65 |
| Dalton Travis | Open Market Purchase | 18.5.2026 | 9,720 | +9,720 | $12.92 |
| Kim Michael | Open Market Purchase | 18.5.2026 | 185,878 | +3,000 | $16.65 |
| Dalton Travis | Open Market Purchase | 18.5.2026 | 34,672 | +9,720 | $12.92 |
| Dalton Travis | Open Market Purchase | 18.5.2026 | 45,872 | +11,200 | $11.88 |
| Klein Michael Stuart | Grant/Award from Employer | 29.4.2026 | 8,977 | +8,977 | — |
| HARRIS C MARTIN | Grant/Award from Employer | 29.4.2026 | 8,977 | +8,977 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
918,699 shares short as of 2026-08-31 · vs. 922,673 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
53.7% of trading volume this week was short selling, vs. 71.2% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology